152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes
The World Health Organisation (WHO) declared COVID-19 a pandemic on 11th March 2020. To mitigate risk of vulnerable lung cancer patients being exposed to COVID-19 due to multiple hospital visits, a contingency hypo-fractionated palliative lung radiotherapy protocol was adopted. This audit aimed to retrospectively evaluate the toxicity and 1 year overall and progression-free survival for different palliative radiotherapy schemes in NSCLC patients.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass Tags: Radiotherapy Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Hospitals | Lung Cancer | Non-Small Cell Lung Cancer | Palliative | Pandemics | Toxicology | WHO